The collaboration aims to advance the discovery and development of novel oral candidates.

Merck also introduces the first perioperative anti-PD-1 treatment regimen for adults with resectable locally advanced head ...

Mitsubishi Research Institute and Astellas have agreed on a memorandum of understanding to provide drug-discovery startups in ...

Nuvation Bio Inc., a global oncology company, received U.S. Food and Drug Administration (FDA) approval of Ibtrozi ...

TekniPlex Healthcare has commenced production activities at its new 200,000-square-foot facility in Madison, Wisconsin.

Cryoport Inc. has completed the previously announced divestiture of its specialty courier business, CRYOPDP, to DHL Group.

The research program will combine Debiopharm’s AbYlink conjugation technology with Alkyon’s modular antibody platform and ...

Novo Nordisk and Deep Apple Therapeutics Inc. have entered a research collaboration and exclusive license agreement.

OncoACP3 is a small molecule ligand with high affinity and specificity for Acid Phosphatase 3 (ACP3), a novel target in ...

Schreiner MediPharm, a global provider of functional label solutions for the healthcare industry, has introduced the Smart ...

PL BioScience GmbH, a German life science company, has appointed Oliver Dick, PhD, as Chief Technology Officer.

The ExPERT and IRO platforms were integrated to improve the yield of gene-edited T cells and shorten manufacturing timelines.